These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Common and alternate oral antibiotic therapies for acne vulgaris: a review. Amin K, Riddle CC, Aires DJ, Schweiger ES. J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358 [Abstract] [Full Text] [Related]
27. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne]. Noyon V, Legallou F, Richet H, Dreno B. Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860 [Abstract] [Full Text] [Related]
28. [Oxytetracycline--mechanism of action and application in skin diseases]. Olszewska M. Wiad Lek; 2006 Dec; 59(11-12):829-33. PubMed ID: 17427500 [Abstract] [Full Text] [Related]
29. New, relevant information and innovative interventions in the management of acne. Danby FW. G Ital Dermatol Venereol; 2011 Jun; 146(3):197-210. PubMed ID: 21566550 [Abstract] [Full Text] [Related]
31. Antibiotic resistance in the topical treatment of acne vulgaris. Leyden JJ. Cutis; 2004 Jun 15; 73(6 Suppl):6-10. PubMed ID: 15228128 [Abstract] [Full Text] [Related]
32. Tetracycline actions relevant to rosacea treatment. Korting HC, Schöllmann C. Skin Pharmacol Physiol; 2009 Jun 15; 22(6):287-94. PubMed ID: 19786821 [Abstract] [Full Text] [Related]
33. Antimicrobials in the treatment of acne and rosacea. Witkowski JA, Parish LC. Skinmed; 2003 Jun 15; 2(4):202. PubMed ID: 14673270 [No Abstract] [Full Text] [Related]
34. [Doxycycline]. Bonnetblanc JM. Ann Dermatol Venereol; 2002 Jun 15; 129(6-7):874-82. PubMed ID: 12218915 [Abstract] [Full Text] [Related]
35. A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea. Sanchez J, Somolinos AL, Almodóvar PI, Webster G, Bradshaw M, Powala C. J Am Acad Dermatol; 2005 Nov 15; 53(5):791-7. PubMed ID: 16243127 [Abstract] [Full Text] [Related]
36. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. Patel M, Bowe WP, Heughebaert C, Shalita AR. J Drugs Dermatol; 2010 Jun 15; 9(6):655-64. PubMed ID: 20645527 [Abstract] [Full Text] [Related]
37. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Leyden JJ, Del Rosso JQ, Webster GF. Cutis; 2007 Jun 15; 79(6 Suppl):9-25. PubMed ID: 17649854 [Abstract] [Full Text] [Related]
38. Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects. Nord CE, Oprica C. Anaerobe; 2006 Jun 15; 12(5-6):207-10. PubMed ID: 17000123 [No Abstract] [Full Text] [Related]
39. General considerations by a clinical bacteriologist regarding antibiotic therapy in acne. Holm SE, Burman LG. Acta Derm Venereol Suppl (Stockh); 1980 Jun 15; Suppl 89():83-5. PubMed ID: 6451131 [No Abstract] [Full Text] [Related]
40. Acne and Propionibacterium acnes. Bojar RA, Holland KT. Clin Dermatol; 2004 Jun 15; 22(5):375-9. PubMed ID: 15556721 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]